Chengdu Kanghong Pharmaceuticals Group Co Ltd

Overview

Chengdu Kanghong Pharmaceuticals Group Co Ltd (Chengdu Kanghong Pharmaceuticals) is a pharmaceutical company that develops, manufactures and markets Chinese medicines, chemical drugs and biological products. The company offers products for the treatment of medical conditions related to central nervous system, ophthalmology, digestive system, gastrointestinal, diabetic nephropathy, and others. It provides medicines for the treatment of hypertension, aripiprazole for anti-psychotic treatment, hyperlipidemia, and venlafaxine hydrochloride sustained release tablets for the treatment of depression. The company offers its products in the form of dispersible tablets, ophthalmic injection, oral drugs, detoxification drugs and antiviral medicines. Chengdu Kanghong Pharmaceuticals is headquartered in Chengdu, Sichuan, China.
Key Stats
Address
No. 36 Shuxi Road, Jinniu District, Jinniu District, CHENGDU, Sichuan
Headquarters

China

Contact

86 28 87502055

Website
www.cnkh.com
No of Employees

3,882

Industry

Pharmaceuticals and Healthcare

Ticker Symbol & Exchange​

002773 [SZSE]

Revenue (2020)

$478 m

1.4% (2020 vs 2019)
Net Income (2020)

$-39 m

-137.5% (2020 vs 2019)
Net Profit Margin

-8 %

-137.1% (2020 vs 2019)
Market Cap *

$2,742 m

EPS *

$-0

  *Note: Ratios based on the share price as of 8-September-2021, in absolute numbers and US$.

Peer Comparison

Key Parameters Chengdu Kanghong Pharmaceuticals Group Co LtdShanghai Pharmaceuticals Holding Co LtdYunnan Baiyao Group Co Ltd
Key Information
Headquarters China China China
Headquarter City CHENGDU SHANGHAI KUNMING
Headquarter State/Province Sichuan Shanghai Yunnan
No. of Employees 3,882 48,136 8,131
Entity Type Public Public Public

Products & Services

Chengdu Kanghong Pharmaceuticals operates as a pharmaceutical company. Key products of the company include the following:

Products
  • Chinese Medicines
  • Biological Products
  • Chemical Drugs
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
  • Vitae Eget Libero
Key Financial Charts
Sales Growth
Operating Margin
Net Income Growth
EPS (Earnings per Share)
Debt to Equity Ratio
Return on Assets

Employees

Name Position Board Since Age Biography
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.
Non Dignissim Eros Proin vel Convallis 2015 XX In vitae nisi ut tortor rutrum suscipit vel vitae ligula. Mauris sed tellus non augue ultricies ultricies. Aliquam vitae urna congue.

History

Year Event Description
2017 Contracts/Agreements In October, Chengdu Kanghong signed an agreement with INC Research for ConocoPhillips ophthalmic injection for…
1996 Incorporation/Establishment The company was established in 1996.

Locations


Kanghong Sagent Pharmaceutial Co Ltd
Chengdu Kanghong Biotechnology Co Ltd
Beijing Hongjian Medical Equipment Co., Ltd.
Beijing Kanghong Biological Medicine Co., Ltd.
Chengdu Hongda Pharmaceutical Co., Ltd.
Chengdu Kanghong Pharmaceutical Trading Co., Ltd.
Kanghong Capital Limited
Sichuan Hongda Pharmaceutical Co., Ltd.

Deals

Number of Deals
Deal Value (US$ m)

Latest Deals

Announced Date Headline Deal Type Acquirers / Investors / Surviving Entity Issuer / partner / Target
21 Dec 2018 Chengdu Kanghong Pharmaceuticals Group Co Ltd Enters Phase III Clinical Trial Agreement with Syneos Health Inc for conbercept (GDCT0330807) Contract Service Agreement Chengdu Kanghong Pharmaceuticals Group Co Ltd; Chengdu Kanghong Pharmaceuticals Group Co Ltd Syneos Health Inc; Syneos Health Inc
25 Sep 2018 Chengdu Kanghong Pharmaceuticals Group Co Ltd Enters Phase III Clinical Trial Agreement with FGK Clinical Research GmbH for conbercept (GDCT0327229) Contract Service Agreement Chengdu Kanghong Pharmaceuticals Group Co Ltd; Chengdu Kanghong Pharmaceuticals Group Co Ltd Syneos Health Inc; FGK Clinical Research GmbH
20 Oct 2017 Chengdu Kanghong Enters into Agreement with INC Research Partnership Chengdu Kanghong Pharmaceuticals Group Co Ltd; Syneos Health NC LLC
19 Oct 2016 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
26 Jan 2016 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit
16 Jun 2015 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit

Jobs Overview

14

Active Jobs

0

Posted

0

Closed

Job Trends

Latest Jobs

Job title Company Country
Director of Microbiological Laboratory Chengdu Kanghong Pharmaceuticals Group Co Ltd China
Engineering equipment technician Chengdu Kanghong Pharmaceuticals Group Co Ltd China
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar
Cras Malesuada Dolor nisi Lorem minim amet cillum elit. Cursus Sed Pulvinar